Health

Henlius' 4th Biologics: Bevacizumab Biosimilar Hanbeitai Approved by National Medical Products Administration

SHANGHAI, Dec. 4, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that bevacizumab biosimilar Hanbeitai, developed and manufactured by Henlius independently, has been approved by the National Medical Products Administration (NMPA). It is indicated for the treatment of meta...

2021-12-04 01:51

I-Mab Announces First Two Patients Dosed in U.S. Phase 2 Combination Trial of Uliledlimab with Atezolizumab in Patients with Selected Advanced Solid Tumors

SHANGHAI and GAITHERSBURG, Md., Dec. 3, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first two patients have been dosed in the U.S. p...

2021-12-03 21:00 563

OrigiMed announced its strategic partnership with Janssen to develop clinical innovative solutions driven by data science

SHANGHAI, Dec. 3, 2021 /PRNewswire/ -- OrigiMed Co., Ltd. ("OrigiMed") announced that the company has signed a memorandum of understanding (MoU) on strategic collaboration with Janssen (China) Research and Development Center of Johnson & Johnson (China) Investment Co., Ltd. ("Janssen").Zili Li, M...

2021-12-03 17:01 863

Biotheus' Bifunctional Therapeutic PM8001 has been Approved by the USFDA to Enter Phase II Studies

ZHUHAI, China, Dec. 3, 2021 /PRNewswire/ -- Biotheus Inc., has announced that its proprietary anti-PD-L1/TGF-β bifunctional therapeutic, named PM8001, has been approved by the USFDA (United States Food and Drug Administration) for conducting clinical phase II studies as part of an international m...

2021-12-03 16:23 701

Mongolian Government To Build On COVID-19 Vaccine And Booster Success

* Mongolia secures nearly 70% vaccination rates and an overall casualty rate of only 0.3% * Successes against COVID-19 position country well for ambitious and progressive reforms as part of government's Vision 2050 agenda ULAANBAATAR, Mongolia, Dec. 3, 2021 /PRNewswire/ -- Mongolia is prepari...

2021-12-03 15:00 709

Elekta's new sustainability-linked bond oversubscribed

STOCKHOLM, Dec. 3, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has issuedSEK 1.5 billion senior unsecured sustainability-linked bonds under its Medium Term Note Program (MTN-Program). One of the bonds, in the amount of SEK 1,150 million, has a maturity of 5 years with a coupon ...

2021-12-03 14:54 738

Starpharma signs distribution agreement for VIRALEZE™ antiviral nasal spray in Vietnam

* Starpharma has signed a 5-year supply and distribution agreement for VIRALEZE™ inVietnam * The agreement includes a minimum commitment of 1 million units in the first year * VIRALEZE™ is scheduled to be officially launched in Vietnam today, following its registration for sale this week ...

2021-12-03 14:24 745

RemeGen's Telitacicept and Disitamab Vedotin Enter China's National Reimbursement Drug List for SLE and Gastric Cancer Treatment

YANTAI, China, Dec. 3, 2021 /PRNewswire/ -- RemeGen Co., Ltd. (9995.HK), a commercial-ready biotechnology company, today announced that two of its innovative drugs, a dual-targeted TACI-Fc fusion protein, Telitacicept (RC18) for treating systemic lupus erythematosus (SLE) and a novel antibody-dru...

2021-12-03 13:45 827

Innovent and Lilly Announce Successful Expansion of Sintilimab in China National Reimbursement Drug List to Include Three Additional First-Line Indications

SAN FRANCISCO, INDIANAPOLIS, and SUZHOU, China, Dec. 3, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and ...

2021-12-03 12:37 1130

Ascletis Announces Inclusion in New Catalogue of China National Reimbursement Drug List (NRDL) of ASCLEVIR®/ GANOVO® Regimen, an All-oral Direct Anti-HCV Therapy

HANGZHOU, China and SHAOXING, China, Dec. 3, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that its all-oral direct anti-hepatitis C virus (HCV) ASCLEVIR® (Ravidasvir)/ GANOVO® (Danoprevir) regimen has been included in the Medicine Catalog for National Basic Medical Insu...

2021-12-03 12:05 916

InnoCare Announces Inclusion of Orelabrutinib in China National Reimbursement Drug List

BEIJING, Dec. 2, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a commercial-stage biotech company, announced today that its BTK inhibitor orelabrutinib has been included in the updated National Reimbursement Drug List (NRDL) by the China National Healthcare Security Administration (NHSA). ...

2021-12-03 10:13 741

Yakult Singapore joins virtual Pink Ribbon Walk 2021 to raise awareness for breast cancer

SINGAPORE, Dec. 3, 2021 /PRNewswire/ -- Yakult Singapore is taking part in the virtual edition of the Pink Ribbon Walk organised by the Breast Cancer Foundation (BCF) from 1st  to 31st December 2021. This event honours breast cancer survivors, remembers those who have lost their lives and aims to...

2021-12-03 10:05 828

Decode Genetics Publishes the Largest Ever Study of the Plasma Proteome

REYKJAVIK, Iceland, Dec. 3, 2021 /PRNewswire/ -- In a study published today in Nature genetics, scientists at deCODE genetics , a subsidiary of the pharmaceutical company Amgen, demonstrate how measuring the levels of a large number of proteins in plasma at population scale when combined with dat...

2021-12-03 03:26 1130

Lifestyle superapp Traveloka launches 12.12 campaign with a referral minigame for customers to win more rewards

SINGAPORE, Dec. 2, 2021 /PRNewswire/ -- Traveloka Singapore has launched a 12.12 Super Lifestyle campaign running from November 29 to December 12, 2021. The campaign includes interactive games and rewards for customers on the platform with in-app purchases. As part of ...

2021-12-02 23:08 1209

Hepagene Therapeutics Initiates the RISE Study, a Phase IIa Clinical Trial of HPG1860 in Patients with NASH

SHANGHAI, Dec. 2, 2021 /PRNewswire/ -- Hepagene Therapeutics, Inc, a clinical stage biopharmaceutical company focusing on innovative therapies for patients with liver diseases, today announced that it has screened the first patient in theUSA for the RISE study, a Phase IIa clinical trial of HPG18...

2021-12-02 23:00 828

MingMed Biotechnology Announces U.S. FDA Approval for IND Application of HPK1 Small Molecule Inhibitor PRJ1-3024, and Completion of Phase I Clinical Trials for Dry AMD Treatment Drug QA102

GUANGZHOU, China, Dec. 2, 2021 /PRNewswire/ -- MingMed Biotechnology, a clinical stage company dedicated to developing first-in-class pharmaceutical products, announced recently the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for PRJ1-3024, a ...

2021-12-02 22:00 898

Clarity and Cardinal Health enter into Agreement for Targeted Copper Theranostics

SYDNEY, Dec. 2, 2021 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, and Cardinal Health (NYSE: CAH), are pleased to announce that the companies have entered ...

2021-12-02 21:58 676

Rayence's Low-Dose Detector "GreenON" Receives Critical Acclaim at RSNA 2021

SEOUL, South Korea, Dec. 2, 2021 /PRNewswire/ -- Rayence(www.rayence.com ) reported that its low-dose detectors "GreenON" received critical acclaim at the RSNA(Radiological Society ofNorth America) 2021.

2021-12-02 21:30 744

Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

HONG KONG, Dec. 2, 2021 /PRNewswire/ -- The Centre for Gut Microbiota Research of the Faculty of Medicine at TheChinese University of Hong Kong (CU Medicine) is among the first in the world to discover that germs in our gut (gut microbiota) modulate our immunity and disease severity in COVID-19. ...

2021-12-02 21:00 1229

SenseTime Expands Presence in Macau to Support City's Economic Diversification

MACAU, Dec. 2, 2021 /PRNewswire/ -- SenseTime, a leading global artificial intelligence (AI) company, hosted an industry forum themed "AI+: Co-Creation" at the first BEYOND Expo inMacau today, during which it announced the official launch of itsMacau office, a significant move to demonstrate its ...

2021-12-02 20:08 825
12345 ... 605